Possible Mechanisms of Insulin Resistance in Obese Subjects

Authors

  • Hala Mourad Demerdash Assistant Professor Department of Clinical Pathology Pharos University Hala Mourad Demerdash, MD Alexandria, Egypt

DOI:

https://doi.org/10.17140/OROJ-2-118

Keywords:

triglyceride, adipocytes

Abstract

Obesity is characterized by excessive triglyceride accumulation in adipose tissue cells
(adipocytes); the adipocytes are not just a reservoir for storage of energy in the form of triglyceride, but more importantly act as endocrine cells; they secrete several hormones as leptin and
adiponectin, also secrete adipokines as TNF-α, Interleukin 6 (IL-6) and Plasminogen activator
inhibitor-1 (PAI-1). In obese subjects, adipocytes release high levels of free fatty acids (FFA)
and its metabolites; Diacylglycerol (DAG) and ceramide.1
Acquired insulin resistance is associated with obesity. Insulin resistance is classically
defined as impaired insulin-mediated glucose disposal in skeletal muscle. There are several
mechanisms responsible for insulin resistance in obese subjects, which can be classified into
either to activation of inflammatory pathways or changes in lipoproteins and apoprotein concentrations as result of associated dyslipidemias

References

Muoio DM. Intramuscular triacylglycerol and insulin resis-tance: guilty as charged or wrongly accused? Biochim Biophys Acta. 2010; 1801(3): 281-288. doi: 10.1016/j.bbalip.2009.11.007

Vergès B, Petit JM, Duvillard L, et al. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol. 2006; 26: 1364-1369. doi: 10.1161/01. ATV.0000219611.50066.bd

Sun X, Liu F. Phosphorylation of IRS proteins. Yin-Yang regulation of insulin signaling. Vitam Horm. 2009; 80: 351-387. doi: 10.1016/S0083-6729(08)00613-4

Odegaard J, Ricardo-Gonzalez R, Red E, et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metabolism. 2008; 7(6): 496- 507. doi: 10.1016/j.cmet.2008.04.003

Yadav A, Kataria M, Saini V, Yadav A. Role of leptin and adi-ponectin in insulin resistance. Clin Chim Acta. 2013; 18(417): 80-84.

Demerdash H, Sharara G, Katri K. Differential effects of gastric bypass and banding on the cardiovascular risk profile in morbidly obese subjects: The correlation with plasma apolipo-protein A-IV concentration. Alexandria Journal of Medicine. 2013; 49(1): 17-23. doi: 10.1016/j.ajme.2012.07.002

Haas M, Attie A, Biddinge S. The regulation of ApoB metabo-lism by insulin. Trends in Endocrinology and Metabolism. 2013; 24(8): 339-397. doi: 10.1016/j.tem.2013.04.001

van der Ham RL, Alizadeh Dehnavi R, Berbée JF, et al. Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome. Diabetes Care. 2009; 32: 184-186. doi: 10.2337/dc08-1330

Bach-Ngohou K, Ouguerram K, Nazih H, et al. Apolipopro-tein E kinetics: influence of insulin resistance and type 2 diabe-tes I Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Int Journal of obesity. 2002; 26(11): 1451- 1458. doi: 10.1038/sj.ijo.0802149

Downloads

Published

2015-03-15

How to Cite

Hala Mourad Demerdash. (2015). Possible Mechanisms of Insulin Resistance in Obese Subjects. Obesity Research, 117–118. https://doi.org/10.17140/OROJ-2-118

Issue

Volume 2 Issue 4 2015

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Obesity Research (OR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.